Genetic Markers Associated with Statin-Induced Myalgia and myopathy
ID Number 09-0089Principal Investigator(s)
Donald A Smith
Department(s) or Division(s)
The Zena and Michael A. Wiener Cardiovascular Institute
The purpose of this study is to determine genetic variants in a specific population that may produce myopathy in the presence of statins, thus leading to possible mechanisms of such myopathies. In families with such myopathies, such gene variants could be screened for, prior to placing other family members on statins.
Recruiting Patients: Yes